针对羟考酮的噬菌体病毒样颗粒疫苗可诱导高滴度长效抗体并将药物隔离于血液中
在美国2021年报告8万例阿片类药物过量相关死亡的背景下,本研究将羟考酮衍生物通过巯基-胺反应性异双功能交联剂高载量偶联至预形成的Qβ噬菌体病毒样颗粒(VLP),在小鼠中肌肉注射免疫可诱导高滴度、高亲和力且持久的抗体应答,疫苗在室温储存超过两周后仍具免疫原性;小鼠抗体可将羟考酮隔离于血清,恒河猴肌肉注射后也诱导出血清羟考酮抗体,作者认为Qβ-羟考酮是有前景的阿片类药物疫苗候选。
要点
- Qβ-羟考酮在小鼠中诱导高滴度、高亲和力且持久的抗体应答。
- 疫苗在室温储存超过两周后仍具免疫原性,显示高度热稳定性。
- 小鼠抗体将羟考酮隔离于血清,恒河猴肌肉注射后也诱导血清羟考酮抗体。
核心结论
- Qβ-羟考酮在小鼠和恒河猴中具免疫原性,作者认为其是有前景的阿片类药物疫苗候选。
研究设计与样本
- 将羟考酮衍生物用巯基-胺反应性异双功能交联剂高载量偶联至预形成的Qβ噬菌体病毒样颗粒,并在小鼠和恒河猴中评估免疫原性。
主要发现
- 小鼠肌肉注射Qβ-羟考酮诱导高滴度、高亲和力且持久的抗体应答。
- Qβ-羟考酮在室温储存超过两周后仍具免疫原性。
- 小鼠免疫后产生的抗体将羟考酮隔离于血清。
- 恒河猴肌肉注射Qβ-羟考酮后诱导血清羟考酮抗体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Opioid use disorder (OUD) and opioid overdoses are public health emergencies. In 2021, 80,000 opioid overdose associated deaths were reported in the United States. Despite the availability of treatment strategies, including medications for opioid use disorder (MOUD) and naloxone, opioid overdoses continue to increase at an alarming rate. Opioid vaccines are a novel approach to combat the growing crisis with several candidates recently entering human clinical trials. In this study, we investigated Qβ bacteriophage virus-like particles (VLPs) as a vaccine platform for immunogenic display of oxycodone. A derivative of oxycodone was conjugated to pre-formed Qβ VLPs using a sulfhydryl-amine reactive heterobifunctional crosslinker with high loading of oxycodone. In mice, intramuscular immunization with Qβ-oxycodone elicited high-titer, high-avidity and long-lasting antibody responses. Qβ-oxycodone was also immunogenic after storage at ambient room temperature for over two weeks, demonstrating that the vaccine is highly thermostable. In mice, immunization with Qβ-oxycodone elicited antibodies that sequester oxycodone in the serum, an important mechanism for preventing the adverse effects of opioid activity. Finally, Qβ-oxycodone is immunogenic in nonhuman primates, eliciting serum oxycodone antibodies after intramuscular immunization of rhesus macaques. These data establish Qβ-oxycodone as a promising opioid vaccine candidate.
引用
- Romano IG, Core SB, Lee NR, et al. A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood. Vaccine. 2023. PMID: 38160131. doi:10.1016/j.vaccine.2023.12.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。